| 영문 | beta human chorionic gonadotropin | 한글 | 베타 사람융모성 생식샘자극호르몬 |
|---|---|---|---|
| 설명 | 태반세포에서 만들어지는 호르몬. 기능은 임신의 초기에 황체(원래 난자를 싸고 있던 세포들이 배란이 일어나서 난자가 빠져나간 후 주머니 모양을 이룬 것. 임신초기에 임신의 유지에 필요한 호르몬을 생성한다)의 유지에 기여하고, 태아의 고환조직에서 남성호르몬이 분비되는 것을 촉진시킨다. 또 이것은 임신초기의 임산부의 소변에서 많은 양이 검출되므로 이것을 이용해서 임신의 여부를 손쉽게 조사할 수가 있다. |
||
| rHuEpo | recombinant human erythropoietin |
|---|---|
| ERC | endoscopic retrograde cholangiography; enteric cytopathic human orphan-rhino-coryza [virus]; erythro... |
| HuEPO | human erythropoietin |
| IFLrA | recombinant human leukocyte interferon A |
| rhG-CSF | recombinant human granulocyte colony-stimulating factor |
| r-HuEPO | Human recombinant erythropoietin |
|---|---|
| r-HuEPO | Recombinant Human Erythropoietin |
| rEpo | Recombinant human erythropoietin |
| R-EPO | Recombinant erythropoietin |
| H-EPO | human erythropoietin |
| erythropoietin, recombinant | Erythropoietin prepared by recombinant DNA technology. (12 Dec 1998) |
|---|---|
| receptors, erythropoietin | Cell surface proteins that bind erythropoietin with high affinity and trigger intracellular changes influencing the behaviour of cells. (12 Dec 1998) |
| serum erythropoietin | <protein> Erythropoietin is a protein hormone which is produced by specialised cells in the kidneys. These cells are sensitive to low arterial oxygen concentration and will release erythropoietin when oxygen is low. Erythropoietin stimulates the bone marrow to produce more red blood cells (to increase the oxygen caring capacity of the blood). The measurement of this hormone in the bloodstream can indicate bone marrow disorders or kidney disease. Normal levels of erythropoietin are 0 to 19 mU/ml (milliunits per millilitre). Elevated levels can be seen in polycythaemia vera. Lower than normal values are seen in chronic renal failure. (27 Sep 1997) |
| erythropoietin | <growth factor, hormone> Erythropoietin is a Glycoprotein (46 kD) hormone produced by specialised cells in the kidneys that regulates the production of red blood cells in the marrow. These cells are sensitive to low arterial oxygen concentration and will release erythropoietin when oxygen is low. Erythropoietin stimulates the bone marrow to produce more red blood cells (to increase the oxygen caring capacity of the blood). The measurement of this hormone in the bloodstream can indicate bone marrow disorders or kidney disease. Normal levels of erythropoietin are 0 to 19 mU/ml (milliunits per millilitre). Elevated levels can be seen in polycythaemia rubra vera. Lower than normal values are seen in chronic renal failure.Recombinant erythopoeitin is now being used therapeutically in patients. Acronym: EPO (27 Sep 1997) |
| recombinant | <molecular biology> A cell or an individual with a new combination of genes not found together in either parent, usually applied to linked genes. (18 Nov 1997) |
| recombinant clone | <molecular biology> Clones containing recombinant DNA molecules. See: recombinant DNA technologies. (14 Oct 1997) |
| recombinant clones | Clones containing recombinant DNA molecules. (12 Dec 1998) |
| recombinant DNA | <molecular biology> Spliced DNA formed from two or more different sources that have been cleaved by restriction enzymes and joined by ligases. (18 Nov 1997) |
| recombinant DNA molecules | A combination of DNA molecules of different origin that are joined using recombinant DNA technology. (12 Dec 1998) |
| recombinant DNA technologies | Procedures used to join together DNA segments in a cell-free system (an environment outside a cell ororganism). Under appropriate conditions, a recombinant DNA molecule canenter a cell and replicate there, either autonomously or after it hasbecome integrated into a cellular chromosome. (09 Oct 1997) |
| recombinant DNA technology | A series of procedures used to join together (recombine) DNA segments. A recombinant DNA molecule is constructed (recombined) from segments from 2 or more different DNA molecules. Under certain conditions, a recombinant DNA molecule can enter a cell and replicate there, autonomously (on its own) or after it has become integrated into a chromosome. (12 Dec 1998) |
| recombinant fusion proteins | Proteins that are the result of genetic engineering. A regulatory part or promoter of one or more genes is combined with a structural gene. The fusion protein is formed after transcription and translation of the fused gene. This type of fusion protein is used in the study of gene regulation or structure-activity relationships. They might also be used clinically as targeted toxins (immunotoxins). (12 Dec 1998) |
| recombinant proteins | Proteins prepared by recombinant DNA technology. (12 Dec 1998) |
| recombinant strain | <molecular biology> A cell or an individual with a new combination of genes not found together in either parent, usually applied to linked genes. (18 Nov 1997) |
| recombinant vector | A vector into which a foreign DNA has been inserted. Synonym: vector. (05 Mar 2000) |
| recombinant human erythropoietin |
A drug used to treat anemia in patients. The form used in the United States is epoetin alfa (trade names Epogen?and Procrit?. Other forms, epoetin beta and epoetin omega, are available outside the United States. This drug is a genetically engineered form of erythropoietin, a hormone produced by the kidneys which regulates the production of red blood cells.
출처: www.anemia.org/patients/glossary/
|
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|